KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $2.9 billion.

  • Bio-Rad Laboratories' Total Non-Current Liabilities rose 1169.77% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year increase of 1169.77%. This contributed to the annual value of $2.9 billion for FY2025, which is 1169.77% up from last year.
  • According to the latest figures from Q4 2025, Bio-Rad Laboratories' Total Non-Current Liabilities is $2.9 billion, which was up 1169.77% from $2.8 billion recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Total Non-Current Liabilities registered a high of $4.4 billion during Q3 2021, and its lowest value of $2.6 billion during Q4 2024.
  • Its 5-year average for Total Non-Current Liabilities is $3.3 billion, with a median of $3.3 billion in 2021.
  • In the last 5 years, Bio-Rad Laboratories' Total Non-Current Liabilities soared by 4622.26% in 2021 and then tumbled by 2285.03% in 2022.
  • Bio-Rad Laboratories' Total Non-Current Liabilities (Quarter) stood at $3.9 billion in 2021, then decreased by 6.14% to $3.7 billion in 2022, then decreased by 8.88% to $3.4 billion in 2023, then decreased by 22.16% to $2.6 billion in 2024, then increased by 11.7% to $2.9 billion in 2025.
  • Its Total Non-Current Liabilities was $2.9 billion in Q4 2025, compared to $2.8 billion in Q3 2025 and $2.9 billion in Q2 2025.